TIRAP Occurring Loss-of-Function Variant of MyD88 Adaptor-Like D96N Is a Naturally

Signals elicited by TLRs following the detection of microbes are integrated and diversified by a group of four cytoplasmic adaptor molecules featuring an evolutionarily conserved Toll/IL-1R signaling domain. Single nucleotide polymorphisms (SNPs) in TLRs and their adaptor molecules have been shown to influence susceptibility to a range of infectious and other diseases. The adaptor MyD88 adaptor-like (Mal)/Toll/IL-1R–containing adaptor protein is involved in TLR2 and 4 signal transduction by recruiting another adaptor molecule, MyD88, to the plasma membrane. In this study, we used naturally occurring variants of Mal as tools to study the molecular biology of Mal in more detail in cellular model systems and to thereby identify functionally interesting variants whose corresponding nonsynonymous SNPs might be of further epidemiological interest. Of seven reported variants for Mal, we found Mal D96N associated with reduced NF- k B signaling and cytokine production after overexpression in HEK293 and Huh-7 cells. The D96N mutation prevented Mal from recruiting its signaling partner MyD88 to the plasma membrane and altered posttranslational modification of Mal. These findings led us to investigate the frequency of heterozygosity for the corresponding SNP rs8177400 in a Caucasian case-control study on the etiology of lymphoma, a disease in which TLRs have been implicated. Although rs8177400 did not modify lymphoma risk in general, its frequency of heterozygosity was accurately determined to 0.97%. Our data add rs8177400 (D96N) to the list of functionally important variants of Mal and warrant further research into its immunological,

[1]  J. Cerhan,et al.  A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. , 2009, Carcinogenesis.

[2]  F. Vazquez,et al.  A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN , 2009, Proceedings of the National Academy of Sciences.

[3]  J. Anaya,et al.  TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. , 2008, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[4]  J. Kalil,et al.  Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria. , 2008, The Journal of infectious diseases.

[5]  J. Todd,et al.  Analysis of association of the TIRAP (MAL) S180L variant and tuberculosis in three populations , 2008, Nature Genetics.

[6]  T. Hawn,et al.  Toll-like receptor polymorphisms and susceptibility to human disease. , 2008, Clinical science.

[7]  Katherine A. Fitzgerald,et al.  Tyrosine Phosphorylation of MyD88 Adapter-like (Mal) Is Critical for Signal Transduction and Blocked in Endotoxin Tolerance* , 2008, Journal of Biological Chemistry.

[8]  J. Banchereau,et al.  Pyogenic Bacterial Infections in Humans with MyD88 Deficiency , 2003, Science.

[9]  M. Frank,et al.  Structure-function relationships of Toll-like receptor domains through homology modelling and molecular dynamics. , 2007, Biochemical Society transactions.

[10]  M. Netea,et al.  TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans , 2007, Proceedings of the National Academy of Sciences.

[11]  L. O'Neill,et al.  Structure, function and regulation of the Toll/IL‐1 receptor adaptor proteins , 2007, Immunology and cell biology.

[12]  Giorgio Sirugo,et al.  A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis , 2007, Nature Genetics.

[13]  L. Beckmann,et al.  Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk , 2006, Genes and Immunity.

[14]  L. Zhao,et al.  A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. , 2006, The Journal of infectious diseases.

[15]  R. Medzhitov,et al.  Phosphoinositide-Mediated Adaptor Recruitment Controls Toll-like Receptor Signaling , 2006, Cell.

[16]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.

[17]  Toshihiro Tanaka The International HapMap Project , 2003, Nature.

[18]  N. Gay,et al.  Structural Complementarity of Toll/Interleukin-1 Receptor Domains in Toll-like Receptors and the Adaptors Mal and MyD88* , 2003, Journal of Biological Chemistry.

[19]  A. Al-ghonaium,et al.  Pyogenic Bacterial Infections in Humans with IRAK-4 Deficiency , 2003, Science.

[20]  Dirk E. Smith,et al.  Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction , 2001, Nature.

[21]  R. Medzhitov,et al.  TIRAP: an adapter molecule in the Toll signaling pathway , 2001, Nature Immunology.

[22]  L. Tong,et al.  Structural basis for signal transduction by the Toll/interleukin-1 receptor domains , 2000, Nature.

[23]  G. Stark,et al.  Mutant Cells That Do Not Respond to Interleukin-1 (IL-1) Reveal a Novel Role for IL-1 Receptor-Associated Kinase , 1999, Molecular and Cellular Biology.

[24]  G. Hardiman,et al.  A family of human receptors structurally related to Drosophila Toll. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  John P. Overington,et al.  Derivation of rules for comparative protein modeling from a database of protein structure alignments , 1994, Protein science : a publication of the Protein Society.

[26]  G. Petsko,et al.  Structure of the Mg(2+)-bound form of CheY and mechanism of phosphoryl transfer in bacterial chemotaxis. , 1994, Biochemistry.

[27]  M. Simon,et al.  Conserved aspartate residues and phosphorylation in signal transduction by the chemotaxis protein CheY. , 1990, Proceedings of the National Academy of Sciences of the United States of America.